this protocol describes the synthesis of oligo(poly(ethylene glycol) fumarate) (opF; 1-35 kDa; a polymer useful for tissue engineering applications) by a one-pot reaction of poly(ethylene glycol) (peG) and fumaryl chloride. the procedure involves three parts: dichloromethane and peG are first dried; the reaction step follows, in which fumaryl chloride and triethylamine are added dropwise to a solution of peG in dichloromethane; and finally, the product solution is filtered to remove by-product salt, and the opF product is twice crystallized, washed and dried under vacuum. the reaction is affected by the molecular weight of peG and reactant molar ratio. the opF product is cross-linked by radical polymerization by either a thermally induced or ultraviolet-induced radical initiator, and the physical properties of the opF oligomer and resulting cross-linked hydrogel are easily tailored by varying peG molecular weight. opF hydrogels are injectable, they polymerize in situ and they undergo biodegradation by hydrolysis of ester bonds. the expected time required to complete this protocol is 6 d. (in anhydrous dichloromethane) dropwise to the stirring solution of PEG at 0 °C. After addition is completed, the reaction mixture is left to stir at room temperature (20-25 °C) for 48 h as the reaction proceeds. Purification of the OPF product occurs through the removal of dichloromethane by rotary evaporation under reduced pressure; this is followed by the removal of triethylamine hydrochloride salt by filtration after precipitating the salt in ethyl acetate at 40 °C. Triethylamine hydrochloride salt is produced by the reaction between chloride ions from fumaryl chloride and triethylamine. Further purification of the OPF product involves twice crystallizing the oligomer in ethyl acetate by reducing the temperature of the solution to 0 °C. After filtration of the recrystallized mixture, the purified OPF product is washed in ethyl ether. Finally, the OPF product is dried under reduced pressure, resulting in the formation of a powder.
IntroDuctIon
PEG-based polymers for tissue engineering PEG-based polymers have been developed for tissue engineering applications in the form of cross-linked hydrogels because PEG is biocompatible, nonimmunogenic and bio-inert (to cells, tissues and drugs-especially proteins-thereby making PEGbased hydrogels ideal for protein release purposes). As PEG alone shows negligible affinity for cells and biological molecules, numerous specific modulators of cell and tissue behavior can be designed into PEG-based hydrogels by incorporation of cell-binding peptides or cell-modulating growth factors. The incorporation of peptides and/or growth factors can enhance the biological activity of PEG-based biomaterials for tissue-specific applications, an advantage in tissue engineering. PEG hydrogels are not intrinsically degradable; however, degradable segments such as fumarates, polyesters, acetals, disulfides and enzyme-sensitive peptides can be incorporated 1 , thus making it possible to adjust the degradation rate of the material to fit its intended application and providing unique physicochemical properties. OPF is a PEG-based oligomer featuring degradable fumarate ester groups and is the focus of this protocol. Other PEG-based hydrogels featuring fumarate groups include poly(propylene fumarate-co-ethylene glycol) 2 and poly(lactide-co-ethylene oxide-co-fumarate) 3 (the relative advantages and limitations are summarized in Table 1 ).
OPF and its applications
OPF is a linear polyester based on the condensation polymerization between PEG and fumaryl chloride in the presence of triethylamine as a proton scavenger (Fig. 1) . The condensation polymerization (carried out with the reactant feed ratio specified herein) preferably results in the formation of OPF with PEG end groups, as shown previously 4 . The number of PEG molecules incorporated into the OPF oligomer depends strongly on steric considerations because higher-molecular-weight PEG molecules obstruct the addition of fumarate groups to their ends. Therefore, as PEG molecular weight increases, fewer PEG molecules are incorporated into each oligomer and more PEG remains unreacted. During hydrogel fabrication, OPF forms cross-links between fumarate double bonds in the oligomer backbone. The nonpolarized double bond of the fumarate ester group in OPF is far less reactive than acrylic acid esters (e.g., PEG-diacrylate) or amides (e.g., N,N′-methylenebisacrylamide). Therefore, cross-linker molecules are typically added to facilitate the cross-linking reaction and reduce the cross-linking time. An advantage of using OPF as a starting material for hydrogel fabrication, which applies to PEG-based polymers in general, is that the finite chain length of each PEG block results in a fixed distance between cross-links in OPF hydrogels, with the assumption that all the fumarate segments are consumed in cross-linking. This makes control of the hydrogel structure highly precise and responsive to changes in the molecular weight of the PEG starting material 5 . OPF oligomers are composed of PEG-fumaric acid units that undergo ester hydrolysis to break down into their constituent parts. The body processes the fumaric acid by-products by natural mechanisms, as fumaric acid is intrinsically present as a component of the Krebs cycle. The minimal cytotoxicity of OPF oligomers and degradation products has been demonstrated experimentally 6 . Research studies have investigated the physicochemical properties of cross-linked OPF hydrogels 5, 7 . OPF has shown the capacity to support tissue formation in bone 8, 9 , cartilage 10 , osteochondral [11] [12] [13] , tendon 14 , cardiovascular 15 , ocular 16 and neural tissue engineering 17 . Furthermore, OPF hydrogels have supported the encapsulation of various cell types, including mesenchymal stem cells 18 , chondrocytes 19 , embryonic stem cells 15 , primary tendon/ligament fibroblasts 20 , pigment epithelial cells 16 and Schwann cells 17 . In addition to cell encapsulation, OPF hydrogels have been tested for the delivery of growth factors [10] [11] [12] [13] 19, [21] [22] [23] [24] [25] [26] [27] , plasmid DNA [28] [29] [30] [31] , small molecules 17 , nanoparticles 32 and chemotherapeutics 33 . Additional studies have demonstrated techniques for modifying OPF hydrogels with cellbinding moieties [34] [35] [36] [37] [38] [39] as well as with osteoconductive domains 39, 40 .
Overview of the synthesis of OPF
In preparation for the reaction step, various reagents (dichloromethane and PEG) must be treated to remove water in order to improve the reaction conversion and increase the molecular weight of the OPF product. The reaction step is prepared by combining anhydrous dichloromethane and dried PEG (toluene containing PEG melt). The reaction is carried out in an inert atmosphere (the system is purged with nitrogen gas) in a single step by adding separate solutions of triethylamine and fumaryl chloride (in anhydrous dichloromethane) dropwise to the stirring solution of PEG at 0 °C. After addition is completed, the reaction mixture is left to stir at room temperature (20-25 °C) for 48 h as the reaction proceeds. Purification of the OPF product occurs through the removal of dichloromethane by rotary evaporation under reduced pressure; this is followed by the removal of triethylamine hydrochloride salt by filtration after precipitating the salt in ethyl acetate at 40 °C. Triethylamine hydrochloride salt is produced by the reaction between chloride ions from fumaryl chloride and triethylamine. Further purification of the OPF product involves twice crystallizing the oligomer in ethyl acetate by reducing the temperature of the solution to 0 °C. After filtration of the recrystallized mixture, the purified OPF product is washed in ethyl ether. Finally, the OPF product is dried under reduced pressure, resulting in the formation of a powder.
Experimental design
This protocol describes the synthesis of OPF in a one-pot reaction. This protocol involves certain crucial steps that are required in order to achieve high conversion and high-molecular-weight OPF oligomer product. The optimum ratio of moles of PEG, fumaryl chloride and triethylamine should be used as indicated; reactants of high purity should be purchased and further purified as specified, and care should be taken to implement the reaction under an inert atmosphere to the exclusion of water. OPF produced using the methods described herein is suitable for investigational use in biomedical applications, including the formation of injectable, biodegradable hydrogels for cell encapsulation, as scaffolds for tissue engineering and as drug delivery vehicles. The OPF oligomer consists only of biocompatible units; therefore, the degradation products are anticipated to be biocompatible, and this has been shown through in vivo studies 8, 12, [15] [16] [17] 24, 25, 28, 31, 41 . The reactant ratios specified in this protocol were optimized experimentally by measuring the degree of oligomerization and conversion of OPF 4 . Other reactant ratios could be used to achieve different end groups or alternative molecular weight distributions. Fumaryl chloride and triethylamine were reacted with PEG (1 mol PEG/0.9 mol fumaryl chloride and 1 mol fumaryl chloride/2 mol triethylamine). These ratios provide a 10% molar excess of PEG in the condensation reaction with fumaryl chloride and enough triethylamine to remove two chloride ions from each fumaryl chloride molecule.
The molecular weight of the OPF oligomers depends on PEG molecular weight, reactant molar ratio, reactant purity and Minimal cytotoxicity of OPF oligomers and hydrogel degradation products 6 Excellent biocompatibility in vivo 41 Methods to control physical properties less multifarious than PEG-based fumarate di-block and tri-block copolymers Poly(propylene fumarateco-ethylene glycol)
Control of hydrophilic/hydrophobic balance through copolymer ratio and block length 47 Control of ultimate tensile stress and tensile modulus by varying copolymer ratio and block length 48 Excellent biocompatibility in vivo 49 Ability to undergo temperature-responsive gel formation at body temperature 50 Variable molecular weight between cross-links and variable mesh size owing to variation in PPF block length Increased cytotoxicity and acute inflammation with lower co-polymer ratio of PEG to PPF or with lower molecular weight PEG 49 Poly(lactide-co-ethylene oxide-co-fumarate)
Control of hydrophilic/hydrophobic balance through co-polymer ratio and block length 3 Variable molecular weight between cross-links and variable mesh size due to variation in poly(lactic acid) block length Tensile mechanical properties not quantified Moderate cytotoxicity of medium conditioned with hydrogel sol fraction 51 In vivo biocompatibility not investigated reaction time. Typical number-average and weight-average molecular weights of OPF synthesized according to this protocol are listed in Table 2 . Although this protocol focuses on the synthesis of OPF, a brief description of cross-linking methods is instructive. OPF hydrogels are formed by radical polymerization in the presence of either a thermally induced or ultraviolet-induced radical initiator. Thermally induced radical initiators used for OPF hydrogel cross-linking include the water-soluble redox pairs ammonium persulfate/N,N,N′,N′-tetramethylethylenediamine 9, 21 and ammonium persulfate/ascorbic acid 4, 5 , but other combinations of oxidizing agents (sodium persulfate) and reducing agents (sodium ascorbate, magnesium ascorbate-2-phosphate) can be envisioned 42 . Ultraviolet-induced radical initiators used for OPF hydrogel cross-linking include bis(2,4,6-trimethylbenzyl) phenylphosphine oxide 4, 37 and Irgacure 2959 (refs. 20,43) , although many photoinitiators are available. In addition, cross-linking molecules are often used in OPF hydrogel fabrication to reduce cross-linking time and provide suitable handling characteristics for injectable applications. Cross-linkers used in OPF hydrogel fabrication include PEG-diacrylate (M n = 575 Da, 3,400 Da) 6 , N,N′-methylenebisacrylamide 21, 22 and N-vinylpyrrolidone 43 . In this way, OPF hydrogels can be fabricated using a variety of formulations providing a wide range of tunable properties that can be controlled as needed for certain applications, from cell encapsulation to therapeutic molecule delivery. One can find in the literature the hydrogel formulation that would be most appropriate for a specific application. LG-10515-106) •
• proceDure synthesis of opF: drying of dichloromethane • tIMInG ~3 h 1| Add calcium hydride (20 g ) and dichloromethane (700 ml) into a one-necked round-bottomed flask (1 liter) and fit the round-bottomed flask with a condenser and a drying tube filled with Drierite (Fig. 2) . ! cautIon Calcium hydride and dichloromethane are irritating and/or harmful if exposed to the skin or inhaled. Calcium hydride releases flammable gases upon contact with water. Conduct all work in a chemical fume hood. Proper personal protective equipment (lab coat, nitrile gloves and safety glasses) should be worn throughout the procedure.
2|
Stir the mixture using a magnetic stir bar.
3|
Heat the reaction flask to 60 °C using a heating mantle and reflux at 60 °C for 2 h. Under these conditions, calcium hydride reacts with water to form calcium hydroxide and hydrogen gas. The hydrogen gas is allowed to escape from the system through a drying tube.
4| After 2 h, cool the reaction flask to room temperature.  pause poInt Once cooled, the dichloromethane/calcium hydride mixture may be sealed and stored overnight in the fume hood, if necessary.
synthesis of opF: distillation of dichloromethane
• tIMInG ~6 h 5| Attach the flask from Step 4 to the apparatus shown in Figure 3 with a 100-ml receiving flask.
6|
Stir the mixture using a magnetic stir bar and heat the reaction flask to 80 °C with a heating mantle.
7|
Collect the first 30 ml of distillate in the 100-ml receiving flask and then replace the flask with a 1,000-ml receiving flask.  crItIcal step The first 30 ml of distillate may contain residual water and should be discarded.
8|
Continue heating until ~600 ml of anhydrous dichloromethane has been collected in the receiving flask.
9|
Once the desired amount of anhydrous dichloromethane has been collected, cool the reaction flask to room temperature.
10|
Once it has cooled, seal the flask with the remaining mixture from Step 1 and store it in the fume hood, awaiting either reuse of unreacted calcium hydride or disposal.  pause poInt The receiving flask containing the anhydrous dichloromethane distillate may be sealed and stored in the fume hood until Step 17, if necessary.
synthesis of opF: drying of peG • tIMInG ~2 h 11| Add PEG (50 g; 1 kDa, 3 kDa, 10 kDa or 35 kDa, depending on the synthesis plan) and toluene (200 ml) into a one-necked round-bottomed flask (1 liter; Fig. 4 ). (Note: this protocol will produce ~40 g of OPF.) ! cautIon Toluene is irritating and/or harmful if exposed to the skin or inhaled. Conduct all work in a chemical fume hood.
Proper personal protective equipment (lab coat, nitrile gloves and safety glasses) should be worn throughout the procedure.
12|
13|
Heat the reaction flask to 170 °C using a heating mantle.
14|
Measure the distillate using the Barrett distilling receiver and collect the distillate into a 250-ml beaker for disposal. 15| Continue heating until 180 ml of distillate has been collected.
16|
Once the desired amount of distillate has been collected, cool the reaction flask to room temperature and collect any subsequent distillate.  pause poInt Once it has cooled, the reaction flask may be sealed and stored in the fume hood until Step 17, if necessary.
synthesis of opF: initiate reaction • tIMInG ~4.5 h 17| Add 320 ml of anhydrous dichloromethane to the dried PEG (Fig. 5) .
18| Stir the mixture using a magnetic stir bar until the PEG dissolves.
19|
Transfer the PEG solution to a three-necked roundbottomed flask (1 liter).
20|
Mix anhydrous fumaryl chloride (1 mol PEG/0.9 mol fumaryl chloride) with 30 ml of anhydrous dichloromethane in an addition funnel with a stopcock and pressure-equalizing arm. (PEG [mol] = 50 g/M n [g/mol]) (Note: fumaryl chloride is always used in the anhydrous state, as it reacts with water to form HCl and fumaric acid. Fumaryl chloride is distilled at 161 °C, purified from its by-products and stored under nitrogen before its use.) ! cautIon Fumaryl chloride is irritating and/or harmful if exposed to the skin or inhaled. Conduct all work in a chemical fume hood. Proper personal protective equipment (lab coat, nitrile gloves and safety glasses) should be worn throughout the procedure.
21|
Mix triethylamine (1 mol fumaryl chloride/2 mol triethylamine) with 30 ml of anhydrous dichloromethane in a second addition funnel with a stopcock and pressureequalizing arm. ! cautIon Triethylamine is irritating and/or harmful if exposed to the skin or inhaled. Conduct all work in a chemical fume hood. Proper personal protective equipment (lab coat, nitrile gloves and safety glasses) should be worn throughout the procedure.  crItIcal step The recommended molar ratios of PEG, fumaryl chloride and triethylamine have been optimized for high OPF conversion and should be followed precisely to achieve the expected results from this protocol.
22|
Fill the balloon attached to the flow control adapter with N 2 (gas).
23|
Purge the system with N 2 (gas) from the balloon by opening the valve on the flow control adapter and allowing the ungreased glass stoppers on the addition funnels to lift gently.
24|
Initiate rapid stirring (~9) of the PEG solution using a magnetic stir bar.
25|
Cool the reaction flask in an ice bath. 26| Initiate a slow drip of triethylamine (~0.2 Hz).
27|
Initiate a slow drip of fumaryl chloride to match the drip rate of triethylamine as closely as possible.  crItIcal step In order to achieve precise control of the addition rate, the addition funnel can be outfitted with a stopcock featuring a threaded needle valve. With this apparatus the stopcock can be left in the open position and all flow adjustments can be made using the needle valve to avoid excess addition at the beginning of the reaction and tedious adjustment thereafter.
28| Continue the addition of fumaryl chloride and triethylamine for 3 h.  crItIcal step An equal and slow rate of addition of fumaryl chloride and triethylamine improves OPF conversion.
Continued addition for at least 3 h results in OPF oligomers with approximate molecular weights to those listed in table 2.
29|
Once dripping has completed, replace the addition funnels with glass stoppers and continue cooling the reaction flask in the ice bath for 30 min.  crItIcal step The color of the reaction solution will transition from colorless to black during addition of fumaryl chloride and triethylamine. Although this protocol describes our preferred method of OPF synthesis, an alternative approach has been developed that benefited from a report using potassium carbonate (K 2 CO 3 ) as a proton scavenger in poly(propylene fumarate) (PPF) synthesis 44 . The alternative approach uses K 2 CO 3 instead of triethylamine as the proton scavenger 45 , which avoids the formation of colored complexes between triethylamine and fumaryl chloride 46 .
30|
After stirring for 30 min, remove the reaction flask from the ice bath and continue stirring at room temperature for 48 h. purification of opF: workup • tIMInG ~9.5 h 31| Transfer the reacted OPF product to a one-necked round-bottomed flask (1 liter).
32|
Remove dichloromethane from the oligomer solution through rotary evaporation at reduced pressure (500 mbar) using a rotary evaporator and heated water bath (30 °C).
33|
Continue rotary evaporation until ~400 ml of dichloromethane is collected.  pause poInt The flask containing the reacted OPF product may be sealed and stored overnight in the fume hood, if necessary.
34|
Add ethyl acetate (700 ml) to the oligomer solution. ! cautIon Ethyl acetate is irritating and/or harmful if exposed to the skin or inhaled. Conduct all work in a chemical fume hood.
35|
Stir the mixture using a magnetic stir bar and heat the solution to 40 °C using a heating mantle.
36|
After the solution has reached 40 °C, continue heating for 30 min.
37|
Set up an apparatus for vacuum filtration using a vacuum flask (1 liter) and Büchner funnel with no. 40 filter paper.
38|
Filter the reacted OPF product to collect salt in the filter and desalted product in the flask.
39|
Place the flask in an ice bath and allow the OPF product to crystallize for 2 h.
40|
Filter the crystallized product using vacuum filtration (1-liter vacuum flask, no. 40 filter paper) to collect the product in the filter. 
42|
Transfer the product to a beaker (1 liter) and add ethyl ether (500 ml). ! cautIon Ethyl ether is irritating and/or harmful if exposed to the skin or inhaled. Conduct all work in a chemical fume hood. Proper personal protective equipment (lab coat, nitrile gloves and safety glasses) should be worn throughout the procedure.
43|
Stir the mixture using a magnetic stir bar for 10 min.
44|
Filter the product using vacuum filtration (2-liter vacuum flask, no. 40 filter paper) to collect the product in the filter.
45|
Wash the product three times with ethyl ether (1 liter total).
46|
After the final wash step, let the product air dry for 10 min and transfer the OPF product to a glass jar.  crItIcal step The OPF product should appear as a light-brown, dry powder.  pause poInt The product may be sealed and stored overnight in the fume hood, if necessary. ? troublesHootInG purification of opF: drying • tIMInG ~10 h 47| Complete drying of the product in a vacuum-rated desiccator under high vacuum for at least 10 h. ! cautIon The vacuum apparatus should be equipped with a liquid nitrogen-cooled vacuum trap to collect potentially harmful volatile compounds.
48| After ~10 h of drying, purge the jar with N 2 (gas).  crItIcal step Purging the OPF product with N 2 (gas) prevents hydrolytic degradation of the OPF oligomers while in storage.  pause poInt Store the OPF product at − 20 °C.
Determination of the molecular weight of opF • tIMInG ~8 h 49| Determine the molecular weight of the OPF product using GPC with an appropriate column at 30 °C and a flow rate of 1.0 ml min − 1 with degassed chloroform as the eluent. For systems using a refractive index detector, the molecular-weight distributions should be determined relative to a calibration curve generated from PEG standards. Note that both GPC and NMR can be used to determine OPF molecular weight, and the values are typically in agreement 4 . nMr analysis of opF • tIMInG ~1 h 50| Confirm the incorporation of fumarate monomers into the OPF oligomer using 1 
